Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Eckardt

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 22, 1998
Antitumor activity of docetaxelJ R Eckardt
Oncology|October 13, 2001
Feasibility of oral topotecan in previously untreated patients with small-cell lung cancer ineligible for standard therapyJ R Eckardt
Oncology|October 13, 2001
Feasibility of oral topotecan plus intravenous paclitaxel in advanced non-small-cell lung cancerJ R Eckardt
Anti-Cancer Drugs|August 1, 1996
New approaches to the treatment of advanced breast cancerJ R Eckardt
Hematology/Oncology Clinics of North America|April 1, 1994
New drugs in clinical development in the United StatesJ R Eckardt, D D Von Hoff
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
New anticancer agentsG R Weiss, H A Burris, J R Eckardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinomaE Raymond, H A Burris, E K Rowinsky, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
New anticancer agentsT D Brown, H A Burris, J R Eckardt, et al.
Bone Marrow Transplantation|February 1, 1993
Comparison of engraftment and acute GVHD in patients undergoing cryopreserved or fresh allogeneic BMTJ R Eckardt, G D Roodman, D H Boldt, et al.
Journal of the National Cancer Institute|January 5, 1994
Activity of intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitroJ R Eckardt, H A Burris, J G Kuhn, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 22, 1998
Antitumor activity of docetaxelJ R Eckardt
Oncology|October 13, 2001
Feasibility of oral topotecan in previously untreated patients with small-cell lung cancer ineligible for standard therapyJ R Eckardt
Oncology|October 13, 2001
Feasibility of oral topotecan plus intravenous paclitaxel in advanced non-small-cell lung cancerJ R Eckardt
Anti-Cancer Drugs|August 1, 1996
New approaches to the treatment of advanced breast cancerJ R Eckardt
Hematology/Oncology Clinics of North America|April 1, 1994
New drugs in clinical development in the United StatesJ R Eckardt, D D Von Hoff
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
New anticancer agentsG R Weiss, H A Burris, J R Eckardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinomaE Raymond, H A Burris, E K Rowinsky, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
New anticancer agentsT D Brown, H A Burris, J R Eckardt, et al.
Bone Marrow Transplantation|February 1, 1993
Comparison of engraftment and acute GVHD in patients undergoing cryopreserved or fresh allogeneic BMTJ R Eckardt, G D Roodman, D H Boldt, et al.
Journal of the National Cancer Institute|January 5, 1994
Activity of intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitroJ R Eckardt, H A Burris, J G Kuhn, et al.
Pageof 4